Clinical Trial Update: Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial investigated whether yohimbine hydrochloride facilitates fear extinction in individuals with phobic disorders; the study has been com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phobic Disorders

Drugs mentioned

• Yohimbine hydrochloride (yohimbine hydrochloride)

Snippet

Sponsor: VU University of Amsterdam | Conditions: Phobic Disorders | Phase 2, Phase 3 | Status: COMPLETED